Health Condition 1: M1A9- Chronic gout, unspecified
Conditions
Interventions
Intervention1: safoof(powder) of unani formulation: Ingredient:Boozidan(Pyrethrum Indicum)5gm orally in the form of safoof once daily after breakfast with water for 28 days
Control Intervention1: Febu
Sponsors
Central council for Research in Unani Medicine New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Irrespective of all genders Patients between 18-65 years of age Patients Fulfilling the criteria of American College of Rheumatology(ACR) for diagnosing gouty arthritis including clinical features, laboratory and radiological finding , having serum uric acid level >7mg/dl in males and Ë?6mg/dl in females17. Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily
Exclusion criteria
Exclusion criteria: Patients below 18 and above 65 years of age Pregnant and lactating mothers Patients who fail to give consent Patients of gout associated with any systemic disorder which interfere with patient study Patients of gout associated with any severe arthritic condition such as rheumatoid arthritis, septic arthritis. Patients suffering from anemia and other blood dyscrasias like leukemia, haemophilia,etc Patients suffering from congenital gout Any other disease other than Gout(Gouty arthritis).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief in Signs and Symptoms of Chronic gout and normal Uric acid levelsTimepoint: 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safetyTimepoint: 28 days | — |
Countries
India
Contacts
Public ContactDr Towseef Amin Rafeeqi
Regional Research Institute of Unani Medicine
Outcome results
None listed